How dangerous are India’s generic drugs? Very


India relies on the weak oversight of developing countries that make up the bulk of its exports – that’s how it can continue to push substandard and often deadly medicines there. — Bloomberg

FOR a nation that seeks to claim the mantle of “pharmacy to the world,” India is scandalously short on regulatory oversight.

In the last six months, its generic cough syrups have killed dozens of children, its eye drops have caused blindness and its chemotherapy drugs have been contaminated.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
India , genericdrugs , regulation , oversight , scandals

Next In Business News

Selangor Dredging buys Petaling Jaya land for RM63mil
FBM KLCI hits multi-year high, banking stocks lead rally
China extends tariffs on solar-grade polysilicon imports from US, South Korea
Invictus Blue confirms exit of two senior leaders following organisational reset
Oil extends climb on Iran supply disruption concerns
Gold steadies below record US$4,600/oz as investors book profits
Velocity Capital exits MMAG with RM9.4Mil share disposal
Trump vows 25% tariff on countries doing business with Iran
Australia's Lynas Rare Earths CEO to retire after over a decade in role
AirAsia X to be renamed AirAsia from Jan 19

Others Also Read